SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Aurobindo Pharma
Aurobindo Pharma
BSE: 524804|NSE: AUROPHARMA|ISIN: INE406A01037|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jul 30, 17:00
681.90
2.9 (0.43%)
VOLUME 199,872
LIVE
NSE
Jul 30, 17:00
682.45
4.55 (0.67%)
VOLUME 2,967,497
News on Aurobindo Pharma
Select Year: 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Investors over bullishness on India may be key risk: BofAML

12.59 pm | 22 Jul 2014 |  Source: Moneycontrol.com

Over the past two weeks, the brokerahe house met with nearly sixty investors with practically every investor has a bullish stance on Indian equities. ...

Aurobindo Pharma's Q1 results on August 07, 2014

10.11 am | 21 Jul 2014 |  Source: Moneycontrol.com

Aurobindo Pharma Ltd has informed BSE that a Meeting of the Board of Directors of the Company will be held on August 07, 2014, inter alia, to consider...

4 Indian pharma cos ink pact to make cheaper anti-HIV drugs 

10.11 pm | 17 Jul 2014 |  Source: CNBC-TV18

Medicines Patent Pool or MPP, a United Nations-backed organisation that facilitates cheaper HIV treatment in developing countries, has announced fresh...

Sharekhan positive on pharma; prefers Aurobindo, Torrent

7.03 pm | 15 Jul 2014 |  Source: Moneycontrol.com

Sharekhan has come out with its report on pharma sector. The research firm remains positive on the pharmaceutical sector and maintain buy rating on Au...

Prefer Aurobindo Pharma on dips: Ajay Bodke 

9.43 am | 14 Jul 2014 |  Source: CNBC-TV18

According to Ajay Bodke of Prabhudas Lilladher, one may prefer Aurobindo Pharma on dips....

Check Out : Intraday picks for the day 

8.14 am | 14 Jul 2014 |  Source: CNBC-TV18

Meghana V Malkan of malkansview.com advises selling Adani Enterprises with a target of Rs 398-405 and Bharat Petroleum Corporation with a target of Rs...

Bull's Eye: Buy Bata, DHFL; short Titan, Aurobindo Pharma 

8.40 am | 11 Jul 2014 |  Source: CNBC-TV18

Manav Chopra, Nirmal Bang advises buying Bata India for a target price of Rs 1,350 and Jindal Saw for a target price of Rs 85....

Prefer Aurobindo, Cadila, Divis, Torrent Pharma: Sharekhan

1.29 pm | 10 Jul 2014 |  Source: Moneycontrol.com

Sharekhan has come out with its Q1FY2015 pharma earnings preview. According to the research firm, Aurobindo Pharma, Cadila Healthcare, Divis Laborator...

Buy Aurobindo Pharma; target of Rs 930: Religare Capital

4.00 pm | 09 Jul 2014 |  Source: Moneycontrol.com

Religare Capital is bullish on Aurobindo Pharma and has recommended buy rating on the stock with a target of Rs 930 in its July 9, 2014 research repor...

Budget 2014: Is it going to be prudent or populist?: Prabhudas Lilladher

1.48 pm | 09 Jul 2014 |  Source: Moneycontrol.com

Prabhudas Lilladher continues to maintain our market strategy of being fully invested in the market and adding at every fall in the market as we conti...

Buy Aurobindo Pharma, DCB Bank, LIC Housing: Deshmukh 

12.16 pm | 03 Jul 2014 |  Source: CNBC-TV18

Akshata Deshmukh of Trading Networth Capital recommends buying LIC Housing Finance for a target of Rs 340 and Jai Corp for a target of Rs 117....

Bull's Eye: Buy Aurobindo, Titan, Tech Mahindra, Jai Corp 

9.07 am | 03 Jul 2014 |  Source: CNBC-TV18

Akshata Deshmukh, Trading Networth Capital advises buying Aurobindo Pharma for a target price of Rs 795 and DCB Bank for a target price of Rs 89....

Hold Aurobindo Pharma; target of Rs 630: Emkay

5.45 pm | 01 Jul 2014 |  Source: Moneycontrol.com

Emkay Global Financial Services has recommended hold rating on Aurobindo Pharma with a target price of Rs 630, in its research report dated June 30, 2...

Aurobindo Pharma appoints Santhanam Subramanian as CFO

12.29 pm | 01 Jul 2014 |  Source: Moneycontrol.com

Aurobindo Pharma has informed that Mr. Sudhir B Singhi, Chief Financial Officer (CFO) of the Company has relinquished his duties with effect from July...

GDUFA fee: 86 generic drug approvals voluntarily withdrawn

10.10 pm | 27 Jun 2014 |  Source: CNBC-TV18

Drug companies in the US are carefully evaluating their portfolios to give away approvals for those products that are not commercially viable, as thes...

Aurobindo Pharma may touch Rs 810, says Jitendra Panda 

1.37 pm | 26 Jun 2014 |  Source: CNBC-TV18

According to Jitendra Panda, MD & CEO at Peerless Securities, Aurobindo Pharma may touch Rs 810....

Aurobindo Pharma may go above Rs 750: SP Tulsian 

9.44 am | 24 Jun 2014 |  Source: CNBC-TV18

SP Tulsian of sptulsian.com is of the view that Aurobindo Pharma may go above Rs 750....

Buy Aurobindo Pharma; target of Rs 785: Firstcall Research

1.37 pm | 13 Jun 2014 |  Source: Moneycontrol.com

Firstcall Research is bullish on Aurobindo Pharma and has recommended buy rating on the stock with a target of Rs 785 in its June 10, 2014 research re...

Accumulate Aurobindo Pharma; target of Rs 712: Dolat Cap

7.39 pm | 05 Jun 2014 |  Source: Moneycontrol.com

Dolat Capital has maintained accumulate rating on Aurobindo Pharma with a target of Rs 712, in its June 02, 2014 report....

Angel Broking neutral on Aurobindo Pharma

12.22 pm | 05 Jun 2014 |  Source: Moneycontrol.com

Angel Broking has maintained a neutral rating on Aurobindo Pharma, in its June 04, 2014 research report....

1 2 3 4 5
Quick Links for Aurobindo Pharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.